Columnist Betty Vertin has begun thinking about what she'd want in a new home to better accommodate three young men with Duchenne MD.

A new 3D model shows that Duchenne gene therapy can repair muscle fibers but fails to shut down the signals that drive ...

Because technology is a part of columnist Shalom Lim's daily life with Duchenne muscular dystrophy, he weighs in on the ...

After following the Olympics, columnist Robin Stemple envisions a future with new treatments and even a cure for FSHD.

Researchers identified a molecular pathway that can limit muscle repair, a finding that may guide future muscular dystrophy treatments.

Roche has decided to stop developing satralizumab for bone health in Duchenne muscular dystrophy, the company announced.

The president and CEO of the Muscular Dystrophy Association talks about what she's most excited about in neuromuscular disease research.

Dosing has begun in a Phase 2 clinical trial testing the experimental oral therapy SAT-3247 in boys with Duchenne muscular dystrophy (DMD).

Hawken Miller is a talented young journalist who writes feature stories for Muscular Dystrophy News. He covers the latest news and information on a variety of muscular dystrophy topics.

Columnist Shalom Lim has discovered that a personal sense of belonging is built through simple presence. Art can help foster that growth.

Rob Stemple is a lifelong advocate for people with disabilities. He was diagnosed with FSHD in 1971 at age 14. Rob struggled with its’ affects for over 50 years. He lost his eyesight in a devastating ...

Exon skipping is a treatment approach for people with Duchenne muscular dystrophy (DMD) that, while not a cure, may help to make the effects of the genetic disease less severe. Duchenne, the most ...